Literature DB >> 27452206

The emerging role of progesterone receptor membrane component 1 (PGRMC1) in cancer biology.

Michael A Cahill1, Jalal A Jazayeri2, Susan M Catalano3, Shinya Toyokuni4, Zaklina Kovacevic5, Des R Richardson6.   

Abstract

Progesterone receptor membrane component 1 (PGRMC1) is a multi-functional protein with a heme-binding moiety related to that of cytochrome b5, which is a putative progesterone receptor. The recently solved PGRMC1 structure revealed that heme-binding involves coordination by a tyrosinate ion at Y113, and induces dimerization which is stabilized by hydrophobic stacking of heme on adjacent monomers. Dimerization is required for association with cytochrome P450 (cyP450) enzymes, which mediates chemoresistance to doxorubicin and may be responsible for PGRMC1's anti-apoptotic activity. Here we review the multiple attested involvement of PGRMC1 in diverse functions, including regulation of cytochrome P450, steroidogenesis, vesicle trafficking, progesterone signaling and mitotic spindle and cell cycle regulation. Its wide range of biological functions is attested to particularly by its emerging association with cancer and progesterone-responsive female reproductive tissues. PGRMC1 exhibits all the hallmarks of a higher order nexus signal integration hub protein. It appears capable of acting as a detector that integrates information from kinase/phosphatase pathways with heme and CO levels and probably redox status. Copyright Â
© 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; Cytochrome P450; Phosphorylation; SH2-domain; SH3-domain; Signaling

Mesh:

Substances:

Year:  2016        PMID: 27452206     DOI: 10.1016/j.bbcan.2016.07.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  29 in total

Review 1.  Interplay of the iron-regulated metastasis suppressor NDRG1 with epidermal growth factor receptor (EGFR) and oncogenic signaling.

Authors:  Sharleen V Menezes; Sumit Sahni; Zaklina Kovacevic; Des R Richardson
Journal:  J Biol Chem       Date:  2017-06-14       Impact factor: 5.157

Review 2.  Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer.

Authors:  Viroj Boonyaratanakornkit; Nalo Hamilton; Diana C Márquez-Garbán; Prangwan Pateetin; Eileen M McGowan; Richard J Pietras
Journal:  Mol Cell Endocrinol       Date:  2017-11-14       Impact factor: 4.102

3.  The Global Phosphorylation Landscape of SARS-CoV-2 Infection.

Authors:  Mehdi Bouhaddou; Danish Memon; Bjoern Meyer; Kris M White; Veronica V Rezelj; Miguel Correa Marrero; Benjamin J Polacco; James E Melnyk; Svenja Ulferts; Robyn M Kaake; Jyoti Batra; Alicia L Richards; Erica Stevenson; David E Gordon; Ajda Rojc; Kirsten Obernier; Jacqueline M Fabius; Margaret Soucheray; Lisa Miorin; Elena Moreno; Cassandra Koh; Quang Dinh Tran; Alexandra Hardy; Rémy Robinot; Thomas Vallet; Benjamin E Nilsson-Payant; Claudia Hernandez-Armenta; Alistair Dunham; Sebastian Weigang; Julian Knerr; Maya Modak; Diego Quintero; Yuan Zhou; Aurelien Dugourd; Alberto Valdeolivas; Trupti Patil; Qiongyu Li; Ruth Hüttenhain; Merve Cakir; Monita Muralidharan; Minkyu Kim; Gwendolyn Jang; Beril Tutuncuoglu; Joseph Hiatt; Jeffrey Z Guo; Jiewei Xu; Sophia Bouhaddou; Christopher J P Mathy; Anna Gaulton; Emma J Manners; Eloy Félix; Ying Shi; Marisa Goff; Jean K Lim; Timothy McBride; Michael C O'Neal; Yiming Cai; Jason C J Chang; David J Broadhurst; Saker Klippsten; Emmie De Wit; Andrew R Leach; Tanja Kortemme; Brian Shoichet; Melanie Ott; Julio Saez-Rodriguez; Benjamin R tenOever; R Dyche Mullins; Elizabeth R Fischer; Georg Kochs; Robert Grosse; Adolfo García-Sastre; Marco Vignuzzi; Jeffery R Johnson; Kevan M Shokat; Danielle L Swaney; Pedro Beltrao; Nevan J Krogan
Journal:  Cell       Date:  2020-06-28       Impact factor: 41.582

4.  Development of Tetrahydroindazole-Based Potent and Selective Sigma-2 Receptor Ligands.

Authors:  Iredia D Iyamu; Wei Lv; Neha Malik; Rama K Mishra; Gary E Schiltz
Journal:  ChemMedChem       Date:  2019-06-03       Impact factor: 3.466

Review 5.  Pleiotropic Actions of PGRMC Proteins in Cancer.

Authors:  James K Pru
Journal:  Endocrinology       Date:  2022-07-01       Impact factor: 5.051

Review 6.  The Interface of Nuclear and Membrane Steroid Signaling.

Authors:  Lindsey S Treviño; Daniel A Gorelick
Journal:  Endocrinology       Date:  2021-08-01       Impact factor: 4.736

7.  Progesterone receptor membrane component 1 is phosphorylated upon progestin treatment in breast cancer cells.

Authors:  Marina Willibald; Giuliano Bayer; Vanessa Stahlhut; Gereon Poschmann; Kai Stühler; Berthold Gierke; Michael Pawlak; Harald Seeger; Alfred O Mueck; Dieter Niederacher; Tanja Fehm; Hans Neubauer
Journal:  Oncotarget       Date:  2017-08-02

8.  Mesenchyme-derived factors enhance preneoplastic growth by non-genotoxic carcinogens in rat liver.

Authors:  Marzieh Nejabat; Teresa Riegler; Tabea Reitinger; Sandra Subosits; Michael Römer; Johannes Eichner; Martin Bilban; Andreas Zell; Wolfgang W Huber; Rolf Schulte-Hermann; Bettina Grasl-Kraupp
Journal:  Arch Toxicol       Date:  2017-12-21       Impact factor: 5.153

Review 9.  Membrane Associated Progesterone Receptors: Promiscuous Proteins with Pleiotropic Functions - Focus on Interactions with Cytochromes P450.

Authors:  Chang S Ryu; Kathrin Klein; Ulrich M Zanger
Journal:  Front Pharmacol       Date:  2017-03-27       Impact factor: 5.810

10.  miRNome and Functional Network Analysis of PGRMC1 Regulated miRNA Target Genes Identify Pathways and Biological Functions Associated With Triple Negative Breast Cancer.

Authors:  Diego A Pedroza; Matthew Ramirez; Venkatesh Rajamanickam; Ramadevi Subramani; Victoria Margolis; Tugba Gurbuz; Adriana Estrada; Rajkumar Lakshmanaswamy
Journal:  Front Oncol       Date:  2021-07-19       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.